Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 29,204 | 31,126 | 32,448 | 32,985 | 35,627 |
| Cost of Goods | 7,550 | 8,889 | 11,177 | 9,721 | 7,060 |
| Gross Profit | 21,654 | 22,237 | 21,271 | 23,264 | 28,567 |
| Operating Expenses | 25,252 | 26,743 | 25,785 | 56,314 | 256,898 |
| Operating Income | -3,048 | -3,617 | -4,337 | -32,329 | -228,271 |
| Interest Expense | 761 | 758 | 757 | 755 | 752 |
| Other Income | 932 | 850 | 716 | 1,179 | 138 |
| Pre-tax Income | -2,877 | -3,525 | -4,378 | -31,905 | -228,885 |
| Income Tax | 44 | 149 | 132 | 25,479 | 50,659 |
| Net Income Continuous | -2,921 | -3,674 | -4,510 | -57,384 | -279,544 |
| Net Income | $-2,921 | $-3,674 | $-4,510 | $-57,384 | $-279,544 |
| EPS Basic Total Ops | -0.45 | -0.60 | -0.75 | -19.94 | -51.27 |
| EPS Basic Continuous Ops | -0.46 | -0.58 | -0.71 | -20.01 | -51.29 |
| EPS Diluted Total Ops | -0.45 | -0.60 | -0.75 | -19.64 | -51.27 |
| EPS Diluted Continuous Ops | -0.46 | -0.58 | -0.71 | -19.56 | -51.29 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.60 | 0.45 | N/A | N/A |
| EBITDA(a) | $3,236 | $3,202 | $1,466 | $-27,316 | $-217,812 |